- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03565848
Mesenteric Sparing Surgery in Laparoscopic Colorectal Resection for Endometriosis (IRE-1)
September 28, 2021 updated by: Antonio Simone Laganà, Università degli Studi dell'Insubria
Analysis of Surgical Outcomes in Women Undergoing Mesenteric Vascular and Nerve Sparing Surgery in Laparoscopic Segmental Colorectal Resection for Deep Infiltrating Endometriosis
Colorectal resection is a standard surgical treatment of bowel deep infiltrating endometriosis (DIE).
Nevertheless, concerns about different bowel functional outcomes related to radical surgery versus conservative surgery as shaving technique is a topic leading to much debate.
Different surgical approach are used to perform colorectal resection and there is not a standardized technique.
For the same concerns, studies have addressed the mesenteric vascular and nerve preservation both in oncological and benign intestinal disease with improved functional outcome.
Therefore, the aim of this prospective study is to analyze feasibility and safety of mesenteric vascular and nerve Sparing Surgery in laparoscopic segmental colorectal resection for DIE with short and long term follow up.
Women with DIE ,that underwent laparoscopic segmental colorectal resection, will undergo resection performed with inferior mesenteric artery and branching arteries preservation by dissecting adherent to the intestinal wall with mesenteric vascularization and innervation entirely preserved.
Personal history, clinical data, surgical data, short and long term surgical complications and long term outcomes will be recorded.
Symptoms and bowel function will be evaluated before and after surgery.
Study Overview
Status
Not yet recruiting
Conditions
Study Type
Observational
Enrollment (Anticipated)
50
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Antonio Simone Laganà, M.D.
- Phone Number: 00393296279579
- Email: antoniosimone.lagana@asst-settelaghi.it
Study Contact Backup
- Name: Simone Garzon
- Phone Number: 00393470782287
- Email: simone.garzon@univr.it
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 45 years (ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Sampling Method
Non-Probability Sample
Study Population
Women with deep infiltrating endometriosis underwent laparoscopic surgery treatment with segmental intestinal resection.
Description
Inclusion Criteria:
- Patients referred for bowel endometriosis requiring colorectal resection
Exclusion Criteria:
- None
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Women underwent colorectal resection for endometriosis
Women referred for colorectal resection for deep infiltrating endometriosis that underwent laparoscopic segmental colorectal resection performed with mesenteric vascular and nerve sparing surgery.
|
Laparoscopic segmental colorectal resection performed by dissecting adherent to the intestinal wall with mesenteric vascularization and innervation entirely preserved.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in endometriosis related dysmenorrhea evaluated by Numeric Rating Scale for Pain
Time Frame: Change from baseline dysmenorrhea at 60 days after surgery and at 1 year after surgery
|
Dysmenorrhea in 0 - 10 range according to the Numeric Rating Scale for Pain
|
Change from baseline dysmenorrhea at 60 days after surgery and at 1 year after surgery
|
|
Change in endometriosis related dyschezia evaluated by Numeric Rating Scale for Pain
Time Frame: Change from baseline dyschezia at 60 days after surgery and at 1 year after surgery
|
Dyschezia in 0 - 10 range according to the Numeric Rating Scale for Pain
|
Change from baseline dyschezia at 60 days after surgery and at 1 year after surgery
|
|
Change in endometriosis related dyspareunia evaluated by Numeric Rating Scale for Pain
Time Frame: Change from baseline dyspareunia at 60 days after surgery and at 1 year after surgery
|
Dyspareunia in 0 - 10 range according to the Numeric Rating Scale for Pain.
|
Change from baseline dyspareunia at 60 days after surgery and at 1 year after surgery
|
|
Change in endometriosis related dysuria evaluated by Numeric Rating Scale for Pain
Time Frame: Change from baseline dysuria at 60 days after surgery and at 1 year after surgery
|
Dysuria in 0 - 10 range according to the Numeric Rating Scale for Pain.
|
Change from baseline dysuria at 60 days after surgery and at 1 year after surgery
|
|
Change in endometriosis related pelvic chronic pain evaluated by Numeric Rating Scale for Pain
Time Frame: Change from baseline pelvic chronic pain at 60 days after surgery and at 1 year after surgery
|
Pelvic chronic pain in 0 - 10 range according to the Numeric Rating Scale for Pain.
|
Change from baseline pelvic chronic pain at 60 days after surgery and at 1 year after surgery
|
|
Change in bowel symptoms evaluated by Constipation Assessment Scale
Time Frame: Change from baseline bowel symptoms at 60 days after surgery and at 2 year after surgery
|
Bowel symptoms in 0 - 16 range according to the Constipation Assessment Scale.
Constipation Assessment Scale includes eight items, each of which is self-rated by the patient as 'no problem' (score of 0), 'some problem' (score of 1), or 'severe problem' (score of 2).
The item ratings are then summed, so the overall score may range from 0 (no constipation) to 16 (worst possible constipation).
|
Change from baseline bowel symptoms at 60 days after surgery and at 2 year after surgery
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Endometriosis characteristics
Time Frame: intraoperative
|
rAFS classification
|
intraoperative
|
|
Complication rate
Time Frame: Within 6 months after surgery
|
Number of surgical complications (Clavien-Dindo Classification)
|
Within 6 months after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: Antonio Simone Laganà, M.D., Uninsubria
- Principal Investigator: Paola Pomini, M.D., Universita di Verona
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (ANTICIPATED)
May 1, 2022
Primary Completion (ANTICIPATED)
May 1, 2023
Study Completion (ANTICIPATED)
May 1, 2024
Study Registration Dates
First Submitted
May 30, 2018
First Submitted That Met QC Criteria
June 11, 2018
First Posted (ACTUAL)
June 21, 2018
Study Record Updates
Last Update Posted (ACTUAL)
September 30, 2021
Last Update Submitted That Met QC Criteria
September 28, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- IRE-1
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Constipation
-
Peking Union Medical College HospitalInstitute of Process Engineering, Chinese Academy of SciencesNot yet recruitingChronic Constipation | Constipation - Functional | Fecal Microbiota TransplantationChina
-
Hamilton Health Sciences CorporationNot yet recruitingConstipation | Constipation - Functional | Constipation AggravatedCanada
-
Singapore Institute of TechnologyNot yet recruitingConstipation | Diet Modification | Constipation-predominant Irritable Bowel Syndrome | Diet Therapy | Constipation - Functional | Constipation Chronic Idiopathic | Constipation, Signs and Symptoms, Digestive | Dietary Fiber | Dietary Fibers | Constipation Predominant Irritable Bowel Syndrome | Dietary and... and other conditionsSingapore
-
Institute of Medical Sciences and SUM HospitalNot yet recruitingFunctional Constipation | Constipation - Functional | Constipation Chronic Idiopathic | Fecal Impaction | Pediatric Functional ConstipationIndia
-
Peking Union Medical College HospitalRecruitingChronic Constipation | Constipation - Functional | Fecal Microbiota Transplantation (FMT)China
-
Hong Kong Metropolitan UniversityNot yet recruitingConstipation | Constipation Drug Induced | Psychiatric Drug Induced ConstipationHong Kong
-
SK Life Science, Inc.CompletedChronic Constipation | Functional ConstipationUnited States
-
Hong Kong Metropolitan UniversityHospital Authority, Hong KongRecruitingConstipation | Constipation Drug Induced | Psychiatric Drug Induced ConstipationHong Kong
-
Cairo UniversityUnknownChronic Idiopathic Constipation | Functional ConstipationEgypt
-
usMIMA S.L.CompletedConstipation | Constipation Chronic Idiopathic | Constipation; NeurogenicSpain, United Kingdom
Clinical Trials on Mesenteric vascular and nerve sparing surgery in laparoscopic segmental colorectal resection
-
Instituto de Investigacion Sanitaria La FeCompletedColorectal Surgery | LaparoscopySpain
-
Meander Medical CenterRecruitingColon Cancer | Sentinel Lymph Node | Colon Neoplasms | Colon Neoplasm | Colon Surgery | Colon Adenocarcinoma | Fluorescence Guided Surgery | Sentinel Lymph Node Biopsy | Fluorescence | Indocyanine Green (ICG) | Fluorescence Laparoscopy | Fluorescence-guided ResectionNetherlands
-
hui houUnknownLaparoscopic Liver Resection | Vascular Occlusion | TourniquetChina